Pediatric Diabetes Management Market Size, Share, Trends, & Industry Analysis Report By Technology (Connected Devices, Non-connected Devices), By Product, By End User, and By Region

Description

List of Tables

The pediatric diabetes management market size is expected to reach USD 13.87 Billion by 2034, according to a new study by Polaris Market Research. The report "Pediatric Diabetes Management Market Size, Share, Trends, & Industry Analysis Report By Technology (Connected Devices, Non-connected Devices), By Product, By End User, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Pediatric diabetes management focuses on the diagnosis, treatment and monitoring of type 1 and type 2 diabetes in children and adolescents. This includes insulin therapies, digital glucose monitoring systems and integrated care approaches designed for pediatric populations.

Rising incidence of type 1 and type 2 diabetes in children, increasing childhood obesity and early onset of metabolic disorders are key factors driving market growth. Additionally, technological advancements in insulin delivery devices, continuous blood glucose monitoring devices (CGMs), and government-backed screening and education programs are supporting adoption across both developed and emerging markets.

Pediatric Diabetes Management Market Report Highlights

In terms of product, the continuous glucose monitors (CGM) segment is expected to witness the fastest growth, due to high adoption in real-time glucose tracking for pediatric use.

Based on technology, the non-connected segment held the dominant market share in 2024, due to affordability and usage in low-resource regions.

Based on end user, the hospitals segment held the dominant market share in 2024, driven by high diagnosis rates and advanced pediatric care settings.

North America accounted for largest pediatric diabetes management market share in 2024, driven by high disease burden, favorable reimbursement, and advanced clinical infrastructure.

Asia Pacific is expected to grow significantly during the forecast period, fueled by growing diabetes incidence, expanding pediatric endocrinology services and improving healthcare accessibility.

A few global key market players include Medtronic plc, Dexcom, Inc., Abbott Laboratories, Insulet Corporation, F. Hoffmann-La Roche Ltd., Tandem Diabetes Care, Inc., Ypsomed AG, Ascensia Diabetes Care, Glooko, Inc., AgaMatrix, Inc., EOFlow Co., Ltd., and Beta Bionics, Inc.

Polaris Market Research has segmented the market report on the basis of product, technology, end user, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Blood Glucose Monitors (BGM)

Continuous Glucose Monitors (CGM)

Insulin Pumps

Insulin Pens

Insulin Syringes

By Technology Outlook (Revenue, USD Billion, 2020-2034)

Connected Devices

Non-connected Devices

By End User Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

General Hospitals

Children Hospitals

Homecare

Pediatric Clinics

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM6053

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Pediatric Diabetes Management Market Insights

4.1. Pediatric Diabetes Management Market - Market Snapshot
4.2. Pediatric Diabetes Management Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Global Incidence of Pediatric Type 1 Diabetes
  - 4.2.1.2. Adoption of Continuous Glucose Monitoring (CGM) and Insulin Pump Technologies
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Device and Treatment Costs
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Pediatric Diabetes Management Market Trends
4.6. Value Chain Analysis

5. Global Pediatric Diabetes Management Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
5.3. Blood Glucose Monitors (BGM)
- 5.3.1. Global Pediatric Diabetes Management Market, by Blood Glucose Monitors (BGM), by Region, 2020-2034 (USD Billion)
5.4. Continuous Glucose Monitors (CGM)
- 5.4.1. Global Pediatric Diabetes Management Market, by Continuous Glucose Monitors (CGM), by Region, 2020-2034 (USD Billion)
5.5. Insulin Pumps
- 5.5.1. Global Pediatric Diabetes Management Market, by Insulin Pumps, by Region, 2020-2034 (USD Billion)
5.6. Insulin Pens
- 5.6.1. Global Pediatric Diabetes Management Market, by Insulin Pens, by Region, 2020-2034 (USD Billion)
5.7. Insulin Syringes
- 5.7.1. Global Pediatric Diabetes Management Market, by Insulin Syringes, by Region, 2020-2034 (USD Billion)

6. Global Pediatric Diabetes Management Market, by Technology

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
6.3. Connected Devices
- 6.3.1. Global Pediatric Diabetes Management Market, by Connected Devices, by Region, 2020-2034 (USD Billion)
6.4. Non-connected Devices
- 6.4.1. Global Pediatric Diabetes Management Market, by Non-connected Devices, by Region, 2020-2034 (USD Billion)

7. Global Pediatric Diabetes Management Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
7.3. Hospitals
- 7.3.1. Global Pediatric Diabetes Management Market, by Hospitals, by Region, 2020-2034 (USD Billion)
7.4. Homecare
- 7.4.1. Global Pediatric Diabetes Management Market, by Homecare, by Region, 2020-2034 (USD Billion)
7.5. Pediatric Clinics
- 7.5.1. Global Pediatric Diabetes Management Market, by Pediatric Clinics, by Region, 2020-2034 (USD Billion)

8. Global Pediatric Diabetes Management Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Pediatric Diabetes Management Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Pediatric Diabetes Management Market - North America
- 8.3.1. North America: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.3.2. North America: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.3.3. North America: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.3.4. Pediatric Diabetes Management Market - U.S.
  - 8.3.4.1. U.S.: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.3.5. Pediatric Diabetes Management Market - Canada
  - 8.3.5.1. Canada: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
8.4. Pediatric Diabetes Management Market - Europe
- 8.4.1. Europe: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.4.2. Europe: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.4.3. Europe: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.4.4. Pediatric Diabetes Management Market - UK
  - 8.4.4.1. UK: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.4.5. Pediatric Diabetes Management Market - France
  - 8.4.5.1. France: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.4.6. Pediatric Diabetes Management Market - Germany
  - 8.4.6.1. Germany: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.4.7. Pediatric Diabetes Management Market - Italy
  - 8.4.7.1. Italy: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.4.8. Pediatric Diabetes Management Market - Spain
  - 8.4.8.1. Spain: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.4.9. Pediatric Diabetes Management Market - Netherlands
  - 8.4.9.1. Netherlands: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.4.10. Pediatric Diabetes Management Market - Russia
  - 8.4.10.1. Russia: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.4.11. Pediatric Diabetes Management Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
8.5. Pediatric Diabetes Management Market - Asia Pacific
- 8.5.1. Asia Pacific: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.5.4. Pediatric Diabetes Management Market - China
  - 8.5.4.1. China: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.5.5. Pediatric Diabetes Management Market - India
  - 8.5.5.1. India: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.5.6. Pediatric Diabetes Management Market - Malaysia
  - 8.5.6.1. Malaysia: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.5.7. Pediatric Diabetes Management Market - Japan
  - 8.5.7.1. Japan: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.5.8. Pediatric Diabetes Management Market - Indonesia
  - 8.5.8.1. Indonesia: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.5.9. Pediatric Diabetes Management Market - South Korea
  - 8.5.9.1. South Korea: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.5.10. Pediatric Diabetes Management Market - Australia
  - 8.5.10.1. Australia: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.5.11. Pediatric Diabetes Management Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
8.6. Pediatric Diabetes Management Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.6.4. Pediatric Diabetes Management Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.6.5. Pediatric Diabetes Management Market - UAE
  - 8.6.5.1. UAE: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.6.6. Pediatric Diabetes Management Market - Israel
  - 8.6.6.1. Israel: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.6.7. Pediatric Diabetes Management Market - South Africa
  - 8.6.7.1. South Africa: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.6.8. Pediatric Diabetes Management Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
8.7. Pediatric Diabetes Management Market - Latin America
- 8.7.1. Latin America: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.7.4. Pediatric Diabetes Management Market - Mexico
  - 8.7.4.1. Mexico: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.7.5. Pediatric Diabetes Management Market - Brazil
  - 8.7.5.1. Brazil: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.7.6. Pediatric Diabetes Management Market - Argentina
  - 8.7.6.1. Argentina: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)
- 8.7.7. Pediatric Diabetes Management Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Pediatric Diabetes Management Market, by Product, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Pediatric Diabetes Management Market, by Technology, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Pediatric Diabetes Management Market, by End User, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abbott Laboratories
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. AgaMatrix, Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Ascensia Diabetes Care
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Beta Bionics, Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Dexcom, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. EOFlow Co., Ltd.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. F. Hoffmann-La Roche Ltd.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Glooko, Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Insulet Corporation
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Medtronic plc
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Tandem Diabetes Care, Inc.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Ypsomed AG
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development